Literature DB >> 2463903

Regulation of 1,25-dihydroxyvitamin D production in human keratinocytes by interferon-gamma.

D D Bikle1, S Pillai, E Gee, M Hincenbergs.   

Abstract

Interferon-gamma (IFN gamma) and 1,25-dihydroxyvitamin D [1,25-(OH)2D] each have potent antiproliferative and prodifferentiating effects on keratinocytes. Since keratinocytes produce 1,25-(OH)2D, we explored the possibility that IFN gamma acted on keratinocytes in part by regulating 1,25-(OH)2D production. We cultured human neonatal foreskin keratinocytes for various periods of time in the presence of various concentrations of IFN gamma before assessing their ability to produce 1,25-(OH)2D. The production of 1,25-(OH)2D by preconfluent keratinocytes grown in the presence of serum (which retards differentiation) was stimulated by 1.8 nM IFN gamma. Postconfluent keratinocytes did not respond to 1.8 nM IFN gamma. The production of 1,25-(OH)2D by keratinocytes grown in serum-free medium was maximally stimulated by 0.006 nM IFN gamma and inhibited at concentrations greater than 0.06 nM. Keratinocytes grown in 0.1 mM calcium serum-free medium (which prevents differentiation) were more sensitive to both the stimulatory and inhibitory effects of IFN gamma than keratinocytes grown in 1.2 mM calcium serum-free medium (which permits differentiation). The stimulatory effect of IFN gamma on 1,25-(OH)2D production was maximal after 2 days of incubation. Incubations longer than 2 days showed increasingly less stimulation at the low IFN gamma concentrations and increasingly greater inhibition at the higher IFN gamma concentrations. The inhibitory effects of IFN gamma on 1,25-(OH)2D production paralleled the inhibitory effects of IFN gamma on cell growth. Thus, IFN gamma does regulate 1,25-(OH)2D production by keratinocytes. However, this regulation is modulated by the state of keratinocyte proliferation and differentiation and is influenced by calcium and undefined factors in serum. The data are consistent with the possibility that IFN gamma alters keratinocyte differentiation in part by regulating 1,25-(OH)2D production.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2463903     DOI: 10.1210/endo-124-2-655

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  24 in total

1.  Impact of vitamin D3 on cutaneous immunity and antimicrobial peptide expression.

Authors:  Attila S Antal; Yvonne Dombrowski; Sarah Koglin; Thomas Ruzicka; Jürgen Schauber
Journal:  Dermatoendocrinol       Date:  2011-01

Review 2.  Current Controversies: Are Free Vitamin Metabolite Levels a More Accurate Assessment of Vitamin D Status than Total Levels?

Authors:  Daniel D Bikle; Sofie Malmstroem; Janice Schwartz
Journal:  Endocrinol Metab Clin North Am       Date:  2017-12       Impact factor: 4.741

3.  Vitamin D and immune function: understanding common pathways.

Authors:  Daniel D Bikle
Journal:  Curr Osteoporos Rep       Date:  2009-07       Impact factor: 5.096

Review 4.  Antimicrobial peptides and the skin immune defense system.

Authors:  Jürgen Schauber; Richard L Gallo
Journal:  J Allergy Clin Immunol       Date:  2008-04-25       Impact factor: 10.793

Review 5.  Vitamin D metabolism and function in the skin.

Authors:  Daniel D Bikle
Journal:  Mol Cell Endocrinol       Date:  2011-06-01       Impact factor: 4.102

Review 6.  Vitamin D: newly discovered actions require reconsideration of physiologic requirements.

Authors:  Daniel D Bikle
Journal:  Trends Endocrinol Metab       Date:  2010-02-10       Impact factor: 12.015

Review 7.  Extraskeletal actions of vitamin D.

Authors:  Daniel D Bikle
Journal:  Ann N Y Acad Sci       Date:  2016-07       Impact factor: 5.691

Review 8.  Vitamin D metabolism, mechanism of action, and clinical applications.

Authors:  Daniel D Bikle
Journal:  Chem Biol       Date:  2014-02-13

Review 9.  Nonclassic actions of vitamin D.

Authors:  Daniel Bikle
Journal:  J Clin Endocrinol Metab       Date:  2008-10-14       Impact factor: 5.958

Review 10.  The vitamin D pathway: a new target for control of the skin's immune response?

Authors:  Jürgen Schauber; Richard L Gallo
Journal:  Exp Dermatol       Date:  2008-06-28       Impact factor: 3.960

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.